Comparison of keratan sulphate concentrations and the size distribution of proteoglycans in the synovial fluid of patients with osteoarthritis and pyrophosphate arthropathy

Rheumatology International

Volumn 11, Issue 2, 1991, Pages 63-68

  Carroll, G ^a   McCappin, S ^a   Bell, M ^a   Schwarzer, A ^a   Breidahl, P ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Acute pyrophosphate arthropathy; Chronic pyrophosphate arthropathy; Keratan sulphate; Osteoarthritis; Proteoglycans

Indexed keywords

PYROPHOSPHATE;

ADULT; AGED; ARTICLE; CHONDROCALCINOSIS; CONTROLLED STUDY; CRYSTAL; FEMALE; GEL ELECTROPHORESIS; HUMAN; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; SYNOVIAL FLUID;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS; CALCIUM PYROPHOSPHATE; CHROMATOGRAPHY, GEL; COMPARATIVE STUDY; DIPHOSPHATES; FEMALE; HUMAN; KERATAN SULFATE; MALE; MIDDLE AGE; OSTEOARTHRITIS; PROTEOGLYCANS; SUPPORT, NON-U.S. GOV'T; SYNOVIAL FLUID;

EID: 0025741636     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/BF00291147     Document Type: Article

References (40)

1. Prevalence of knee chondrocalcinosis in hospital and clinic patients aged 50 or over
2. Calcium pyrophosphate dihydrate crystal deposition disease
3. A roentgenologically distinctive arthropathy in some patients with pseudogout syndrome. American Journal of Roentgenology
4. Destructive arthropathy in chondrocalcinosis
5. Destructive arthropathy in chondrocalcinosis articularis
6. Destructive arthropathy in generalized osteoarthritis with articular chondrocalcinosis
7. Joint destruction and chondrocalcinosis in patients with generalized osteoarthrosis
8. Clinical, radiographic and pathological abnormalities in calcium pyrophosphate deposition disease (CPPD): pseudogout
9. NTP pyrophosphohydrolase in human chondrocalinotic and osteoarthritic cartilage 1. Some biochemical characteristics
10. Crystal deposition disease
11. Equilibria of calcium and phosphate ions in human articular cartilage
12. Development of criteria for the classification and reporting of osteoarthritis
13. Radiological assessment of osteoarthrosis
14. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue
15. Spectrophotometric measurement of proteoglycans in osteoarthritic synovial fluid
16. Gel electrophoresis of proteoglycans and glycosaminoglycans on large-pore composite polyacrylamide-agarose gels
17. The immunologic detection and characterisation of cartilage proteoglycan degradation products in synovial fluid of patients with arthritis
18. A contribution to the pathogenesis of chondromalacia of the patella: a physical, histologic and chemical study
19. Chondroitin sulfate concentration and protein-polysaccharide composition of articular cartilage in osteoarthritis
20. Two latent metalloproteases of human articular cartilage that digest proteoglycan
21. Metalloproteases of human articular cartilage that digest cartilage proteoglycan at neutral and acid pH
22. Collagenase and collagenolytic activity in human osteoarthritic cartilage
23. Neutral proteases capable of proteoglycan digesting activity in osteoarthritic and normal human articular cartilage
24. Oxygen radicals as effectors of cartilage destruction. Direct degradative effect on matrix components and indirect action via activation of latent collagenase from polymorphonuclear leukocytes
25. Interaction of polymorphonuclear leukocytes with cartilage in vitro. Catabolic effects of serine proteases and oxygen radicals
26. A comparison of glycosaminoglycans content of human synovial fluid in early rheumatoid arthritis and reactive arthritis
27. Difference in cartilage proteoglycan level in synovial fluid in early rheumatoid arthritis and reactive arthritis
28. Therapeutic effects on cartilage metabolism in arthritis as measured by release of proteoglycan structures into the synovial fluid
29. The role of cytokines in arthritic disease: in vitro and in vivo measurements of cartilage degradation
30. Cartilage proteoglycans in synovial fluid and serum in patients with inflammatory joint disease
31. Transient synovitis of the hip in the child: increased levels of proteoglycan fragments in joint fluid
32. Increased concentrations of proteoglycan components in the synovial fluids of patients with acute, but not chronic joint disease
33. Measurement of proteoglycans, elastase, collagenase and protein in synovial fluid in inflammatory and degenerative arthropathies
34. Measurement of sulphated glycosaminoglycans and proteoglycan fragments in arthritic synovial fluid
35. Increased levels of proteoglycan fragments in knee joint fluid after injury
36. The sulphated glycosaminoglycan levels in synovial fluid aspirates in patients with acute and chronic joint disease
37. Structure of proteoglycans from different layers of human articular cartilage
38. The occurrence of a wide variety of dermatan sulfate-chondroitin sulfate copolymers in fibrous cartilage
39. Evidence for an interaction between synovial cell proteoglycans and link proteins
40. Glycosaminoglycans produced by human synovial cell cultures